Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | August 03, 2023 09:06am

Gainers

  • Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 67.2% to $9.13 during Thursday's pre-market session. The company's market cap stands at $9.3 million.
  • T2 Biosystems (NASDAQ:TTOO) stock increased by 49.71% to $0.36. The company's market cap stands at $105.5 million.
  • Biomerica (NASDAQ:BMRA) stock moved upwards by 26.36% to $1.84. The company's market cap stands at $31.0 million.
  • Adamis Pharmaceuticals (NASDAQ:ADMP) shares rose 16.54% to $1.55. The market value of their outstanding shares is at $4.3 million.
  • Assure Hldgs (NASDAQ:IONM) stock rose 15.06% to $0.84. The company's market cap stands at $4.4 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares increased by 13.9% to $0.78. The market value of their outstanding shares is at $3.6 million.

Losers

  • Aravive (NASDAQ:ARAV) stock decreased by 62.4% to $0.48 during Thursday's pre-market session. The market value of their outstanding shares is at $28.6 million.
  • Vicarious Surgical (NYSE:RBOT) stock fell 41.82% to $0.96. The company's market cap stands at $122.2 million.
  • Bio-Path Hldgs (NASDAQ:BPTH) shares fell 36.8% to $0.48. The company's market cap stands at $3.8 million.
  • Schrodinger (NASDAQ:SDGR) stock declined by 19.79% to $40.3. The company's market cap stands at $2.8 billion. As per the news, the Q2 earnings report came out yesterday.
  • Outset Medical (NASDAQ:OM) stock decreased by 13.23% to $16.8. The market value of their outstanding shares is at $827.0 million. As per the press release, Q2 earnings came out yesterday.
  • Staar Surgical (NASDAQ:STAA) stock declined by 13.03% to $45.49. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADMP ARAV BJDX BMRA BPTH IONM OM RBOT SDGR STAA TCBP TTOO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist